Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Indices Close at All Time Highs; Power Stocks Top Gainers
Mon, 27 Aug Closing | Monish Vora, TM Team

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day in green, at a new all-time high close. Sectoral indices too ended the day in green, with stocks in the power sector and stocks in the banking sector leading the gains.

At the closing bell, the BSE Sensex stood higher by 442 points (up 1.2%) and the NSE Nifty closed up by 135 points (up 1.2%). The BSE Mid Cap index ended the day up 1.1%, while the BSE Small Cap index ended the day up by 0.7%.

Asian stock markets finished in green. As of the most recent closing prices, the Hang Seng was up by 2% and the Shanghai Composite was up by 1.9%. The Nikkei 225 was up by 0.8%. Meanwhile, European markets were trading on a positive note. The FTSE 100 was up by 0.2%, The DAX, was up by 0.6% while the CAC 40 was up by 0.5%.

The rupee was trading at Rs 70.11 against the US$ in the afternoon session. Oil prices were trading at US$ 74.8 at the time of writing.

What cycle of the markets are we in? Are we at the peak or is the party set to continue? The Sensex seems to be touching new all-time highs every single day.

We believe that when earnings improve and stock prices also go up, it's time to hold on and enjoy the ride.

--- Advertisement ---
Your Package is in The Mail...Expect it Shortly!

Hundreds of copies of Equitymaster's Secrets: 2018 Limited Edition are now on their way to readers' houses.

We're sure you're waiting eagerly for your book - but if you haven't claimed a copy yet, hurry! You can still reserve your book here.
------------------------------

But the current situation is different. While the Sensex is reaching new highs, the mid cap index and the small cap index have corrected sharply this year.

Also, the recent earnings of non-financial companies present a promising picture. But is it a true picture of what lies ahead?

Is the Growth Story Back for Listed Indian Companies?

For listed non-financial entities, net sales for the June quarter grew by 18.5% over the same quarter last year. Net profits were up by 33.6%.

This is good but remember, it was mainly due to the low base of last year. You see, at this time last year, a lot of companies were severely impacted by the twin effects of demonetisation and the GST implementation.

So, will this growth sustain?

Recent scenarios developing in global markets calls for caution. Rising interest rates and crude oil prices, along with trade wars can be a road-block for emerging markets like India.

With markets at peak levels, I believe a correction cannot be ruled out.

The time to short-list good quality stocks might just be around the corner.

Moving on to news from stocks in the pharma sector. Lupin share price is among the stocks in focus today as the company launched contraceptive drugs in the US.

The company launched Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets and Levomefolate Calcium tablets, in the US markets after it received approval from the US Food and Drug Administration (USFDA) earlier.

Lupin share price ended the day up by 0.6%.

Indian pharma companies catering to the US markets are breathing a sigh of relief. After being adversely affected by import bans and the suspension of new drug approvals from manufacturing facilities in the past three years, there has been a sharp pick-up in new drug approvals in FY17.

With an aim to lower the overall healthcare costs in the country, the US Food and Drug Administration (FDA) approved a record 763 generic drugs for the financial year ending 30th September. As per Mint Analysis, Indian pharma companies received 295 approvals accounting for 40% of the overall approvals during the year.

Even the total filings of abbreviated new drug applications (ANDAs) for generic drugs rose to 1,292 in FY17 from 852 in the previous year. While, faster approvals expedite the commercialisation of product pipelines of domestic pharma companies spurring growth. At the same time however, it has raised the intensity of competition resulting in pricing pressures. The price erosion has been further compounded by a consolidation among US distributors and the decline in the number of products going off-patent over the past few years.

In other words, acceleration in generic drug approvals is like a double-edged sword. The growth boost can be quickly offset by the ensuing pricing pressures. Pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market.

Therefore, despite a lot of pessimism surrounding pharma stocks on regulatory uncertainty, we have stocks in open positions in StockSelect and have remained bullish on pharma stocks in our long term service, ValuePro.

Now you can also listen to our stock market podcast. Just visit SoundCloud, iTunes or Stitcher and access our free weekly podcast. Happy listening!

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian Indices Close at All Time Highs; Power Stocks Top Gainers". Click here!

  

Stock Market Updates

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark (Today's Market)

Mar 5, 2021 Closing

Indian share markets end lower with the Sensex down by 441 points and the Nifty ending down by 143 points.

GRINDWELL NORTON Share Price Down by 5%; BSE CAPITAL GOODS Index Down 1.5% (Today's Market)

Mar 5, 2021 03:30 PM

GRINDWELL NORTON share price is trading down by 5% and its current market price is Rs 950. The BSE CAPITAL GOODS is down by 1.5%. The top gainers in the BSE CAPITAL GOODS Index are V GUARD INDUSTRIES (up 3.3%) and AIA ENGINEERING (up 0.3%). The top losers is GRINDWELL NORTON (down 5.1%).

ADITYA BIRLA CAPITAL Share Price Down by 5%; BSE 500 Index Down 1.1% (Today's Market)

Mar 5, 2021 03:28 PM

ADITYA BIRLA CAPITAL share price is trading down by 5% and its current market price is Rs 131. The BSE 500 is down by 1.1%. The top gainers in the BSE 500 Index are TV18 BROADCAST (up 7.3%) and MOTILAL OSWAL (up 5.9%). The top losers are ADITYA BIRLA CAPITAL (down 5.0%) and APOLLO HOSPITALS (down 5.2%).

HAVELLS INDIA Share Price Down by 5%; BSE CONSUMER DURABLES Index Down 0.7% (Today's Market)

Mar 5, 2021 03:20 PM

HAVELLS INDIA share price is trading down by 5% and its current market price is Rs 1,163. The BSE CONSUMER DURABLES is down by 0.7%. The top gainers in the BSE CONSUMER DURABLES Index are BLUE STAR (up 1.7%) and CROMPTON GREAVES CONSUMER ELEC. (up 1.3%). The top losers is HAVELLS INDIA (down 5.1%).

BALMER LAWRIE Share Price Down by 5%; BSE 500 Index Down 1.1% (Today's Market)

Mar 5, 2021 03:18 PM

BALMER LAWRIE share price is trading down by 5% and its current market price is Rs 148. The BSE 500 is down by 1.1%. The top gainers in the BSE 500 Index are TV18 BROADCAST (up 6.8%) and MOTILAL OSWAL (up 6.1%). The top losers are BALMER LAWRIE (down 5.0%) and APOLLO HOSPITALS (down 5.5%).

TRENT Share Price Down by 5%; BSE 500 Index Down 1.3% (Today's Market)

Mar 5, 2021 03:16 PM

TRENT share price is trading down by 5% and its current market price is Rs 936. The BSE 500 is down by 1.3%. The top gainers in the BSE 500 Index are TV18 BROADCAST (up 6.6%) and MOTILAL OSWAL (up 6.1%). The top losers are TRENT (down 5.4%) and APOLLO HOSPITALS (down 5.5%).

View More Indian Share Market News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Mar 5, 2021 (Close)

MARKET STATS